study on NAFLD with two different drugs ( Majoon Dabidulward and Dawaulkurkum kabir)

A Comparative Evaluation of Majoon Dabidulward with Dawa-ul-Kurkum Kabir in The Management of Su-e-Mizaj Kabid Barid (Non-Alcoholic Fatty Liver Disease) - CTRI

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/082167

Enrollment

Registered

2025-03-12

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: K760- Fatty (change of) liver, not elsewhere classified

Interventions

Intervention1: Majoon Dabidulward: 7 g Once in the morning after breakfast Control Intervention1: Dawaul kurkum kabir: 7 g Once in the morning after breakfast

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of fatty liver (Grade-I and Grade-II) by USG. Patients of either gender Age group of 20-60 years Patient with positive clinical features and fulfil the diagnostic criteria. Non-alcoholic patients

Exclusion criteria

Exclusion criteria: Fatty liver Grade-III, Grade-IV Patient suffering from hepatic biliary carcinoma, cirrhosis and viral hepatitis Diabetic patient Pregnant and lactating women Patient with autoimmune disease like SLE Patient suffering from HIV or AIDS, Hypertension, Atherosclerosis, CAD, CVD, Hemolytic disorders, Nephrotic diseases

Design outcomes

Primary

Measure	Time frame
Decrease in size and fat deposition of liver in USG of abdomen. Relived clinical features. Timepoint: 2 months	—

Secondary

Measure	Time frame
Lipid ProfileTimepoint: 2 months	—

Countries

India

Contacts

Public ContactDr Md Najibur Rahman

Govt. Tibbi College and Hosppital Patna

dr.razi.ahmed91@gmail.com7909035622

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026